Erschienen in:
08.07.2016 | Letter to the Editor
Clinical vertebral fractures following denosumab discontinuation
verfasst von:
Stergios A. Polyzos, Evangelos Terpos
Erschienen in:
Endocrine
|
Ausgabe 1/2016
Einloggen, um Zugang zu erhalten
Excerpt
Denosumab treatment has an established antifracture efficacy for osteoporosis, but there is recent concern for increased vertebral fracture risk following its discontinuation. We would like to present our clinical experience, adding two new cases of clinical vertebral fractures following denosumab discontinuation. Informed consent was obtained from both participants included in the study. …